Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from <i>the International Lipid Expert Panel</i> (ILEP)-Reference-Cited by-同舟云学术

Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

Published:2022-03-10 Issue:3 Volume:13 Page:1596-1622
ISSN:2190-5991
Container-title:Journal of Cachexia, Sarcopenia and Muscle
language:en
Short-container-title:J cachexia sarcopenia muscle

Author:

Penson Peter E.¹²,Bruckert Eric³,Marais David⁴,Reiner Željko⁵,Pirro Matteo⁶,Sahebkar Amirhossein⁷⁸⁹,Bajraktari Gani¹⁰¹¹,Mirrakhimov Erkin¹²,Rizzo Manfredi¹³¹⁴,Mikhailidis Dimitri P.¹⁵,Sachinidis Alexandros¹³¹⁶,Gaita Dan¹⁷¹⁸,Latkovskis Gustavs¹⁹²⁰,Mazidi Mohsen²¹²²,Toth Peter P.²³²⁴,Pella Daniel²⁵,Alnouri Fahad²⁶,Postadzhiyan Arman²⁷,Yeh Hung‐I²⁸,Mancini G.B. John²⁷,von Haehling Stephan²⁹³⁰,Banach Maciej³¹³²³³^ORCID,Acosta Julio,Al‐Khnifsawi Mutaz,Alnouri Fahad,Amar Fahma,Atanasov Atanas G.,Bajraktari Gani,Banach Maciej,Bhaskar Sonu,Bytyçi Ibadete,Bjelakovic Bojko,Bruckert Eric,Cafferata Alberto,Ceska Richard,Cicero Arrigo F.G.,Collet Xavier,Daccord Magdalena,Descamps Olivier,Djuric Dragan,Durst Ronen,Ezhov Marat V.,Fras Zlatko,Gaita Dan,Hernandez Adrian V.,Jones Steven R.,Jozwiak Jacek,Kakauridze Nona,Kallel Amani,Katsiki Niki,Khera Amit,Kostner Karam,Kubilius Raimondas,Latkovskis Gustavs,Mancini G.B. John,Marais A. David,Martin Seth S.,Martinez Julio Acosta,Mazidi Mohsen,Mikhailidis Dimitri P.,Mirrakhimov Erkin,Miserez Andre R.,Mitchenko Olena,Mitkovskaya Natalya P.,Moriarty Patrick M.,Nabavi Seyed Mohammad,Nair Devaki,Panagiotakos Demosthenes B.,Paragh György,Pella Daniel,Penson Peter E.,Petrulioniene Zaneta,Pirro Matteo,Postadzhiyan Arman,Puri Raman,Reda Ashraf,Reiner Željko,Radenkovic Dina,Rakowski Michał,Riadh Jemaa,Richter Dimitri,Rizzo Manfredi,Ruscica Massimiliano,Sahebkar Amirhossein,Sattar Naveed,Serban Maria‐Corina,Shehab Abdullah M.A.,Shek Aleksandr B.,Sirtori Cesare R.,Stefanutti Claudia,Tomasik Tomasz,Toth Peter P.,Viigimaa Margus,Valdivielso Pedro,Vinereanu Dragos,Vohnout Branislav,von Haehling Stephan,Vrablik Michal,Wong Nathan D.,Yeh Hung‐I,Zhisheng Jiang,Zirlik Andreas,

Affiliation:

1. School of Pharmacy and Biomolecular Sciences Liverpool John Moores University Liverpool UK

2. Liverpool Centre for Cardiovascular Science Liverpool UK

3. Pitié‐Salpetrière Hospital and Sorbonne University Cardio metabolic Institute Paris France

4. Chemical Pathology Division of the Department of Pathology University of Cape Town Health Science Faculty Cape Town South Africa

5. Department of Internal Medicine, University Hospital Centre Zagreb School of Medicine University of Zagreb Zagreb Croatia

6. Department of Medicine University of Perugia Perugia Italy

7. Biotechnology Research Center, Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran

8. Applied Biomedical Research Center Mashhad University of Medical Sciences Mashhad Iran

9. Clinic of Cardiology, University Clinical Centre of Kosova, Medical Faculty University of Prishtina Prishtina Kosovo

10. Department of Public Health and Clinical Medicine Umeå University Umeå Sweden

11. Department of Internal Disease Kyrgyz State Medical Academy Bishkek Kyrgyzstan

12. Department of Atherosclerosis and Coronary Heart Disease National Center of Cardiology and Internal Diseases Bishkek Kyrgyzstan

13. Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE) University of Palermo Palermo Italy

14. Division of Endocrinology, Diabetes and Metabolism, School of Medicine University of South Carolina Columbia SC USA

15. Department of Clinical Biochemistry University College London Medical School, University College London (UCL) London UK

16. 2nd Propedeutic Department of Internal Medicine, Medical School Aristotle University of Thessaloniki Thessaloniki Greece

17. Universitatea de Medicina si Farmacie Victor Babes Timisoara Romania

18. Clinica de Cardiologie Institutul de Boli Cardiovasculare Timisoara Timisoara Romania

19. Pauls Stradins Clinical University Hospital Riga Latvia

20. University of Latvia Riga Latvia

21. Medical Research Council Population Health Research Unit University of Oxford Oxford UK

22. Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health University of Oxford Oxford UK

23. CGH Medical Center Sterling IL USA

24. Cicarrone Center for the Prevention of Cardiovascular Disease Johns Hopkins University School of Medicine Baltimore MD USA

25. 2nd Department of Cardiology of the East Slovak Institute of Cardiovascular Disease and Faculty of Medicine PJ Safarik University Kosice Slovak Republic

26. Cardiovascular Prevention Unit, Adult Cardiology Department Prince Sultan Cardiac Centre Riyadh Riyadh Saudi Arabia

27. Department of General Medicine, Emergency University Hospital ‘St. Anna’ Medical University of Sofia Sofia Bulgaria

28. Department of Medicine MacKay Medical College New Taipei City Taiwan

29. Department of Cardiology and Pneumology, Heart Center University of Göttingen Medical Center Göttingen Germany

30. German Center for Cardiovascular Research (DZHK), partner site Göttingen Göttingen Germany

31. Polish Moother's Memorial Hospital Research Institute (PMMHRI) Lodz Poland

32. Department of Preventive Cardiology and Lipidology Medical University of Lodz (MUL) Lodz Poland

33. Cardiovascular Research Centre University of Zielona Gora Zielona Gora Poland

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.12960

Reference116 articles.

1. Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

2. Statins in the primary prevention of cardiovascular disease

3. Interpretation of the evidence for the efficacy and safety of statin therapy

4. Statin-Associated Side Effects

5. Adverse Effects of Statins - Myths and Reality

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Worsening of myasthenic symptoms associated with statins;Journal of the Neurological Sciences;2024-09

2. Statin intolerance and the drucebo effect;QJM: An International Journal of Medicine;2024-07-27

3. A systematic review of the drug-drug interaction between Statins and Quinolones;BMC Pharmacology and Toxicology;2024-07-10

4. Efficacy and Safety of Bempedoic Acid in Patients with High Cardiovascular Risk: An Update;Current Vascular Pharmacology;2024-07

5. Hydroxymethylglutaryl‐CoA reductase activity is essential for mitochondrial β‐oxidation of fatty acids to prevent lethal accumulation of long‐chain acylcarnitines in the mouse liver;British Journal of Pharmacology;2024-04-19